| Latest York Pharma News Headlines |
| Date | Time | Source | |
| 10/03/2008 | 11:46AM | TFNF | York Pharma says finance director Ian Harvey to step down on medical advice
York Pharma Plc. said finance director Ian
Harvey wil step down on medical advice and Simon Ainley will take over his post
in the interim.
The specialist dermatology pharmaceutical company also said it expects to
become self-financing next year and profitable shortly thereafter.
tf.TFN-Europe_newsdesk@thomsonreuters.com
ind/slm
COPYRIGHT
Copyright... More...>> |
| 10/03/2008 | 11:14AM | UKREG | Directorate Change
RNS Number : 0915F
York Pharma plc
03 October 2008
York Pharma plc
("York Pharma" or "the Company")
Directorate Change
London, UK, 3rd October 2008 York Pharma (AIM:YRK), the specialist dermatology pharmaceutical company, regrets to announce that Ian
Harvey, Finance Director, has... More...>> |
| 10/01/2008 | 7:44AM | UKREG | Acquisition
RNS Number : 8339E
York Pharma plc
01 October 2008
York Pharma plc
("York Pharma" or "the Company")
Completion of EUR28.5 million acquisition
of leading dermatological & wound care brands
London, UK, 1 October 2008 York Pharma (AIM:YRK), the specialist dermatology pharmaceutical... More...>> |
| 08/07/2008 | 8:47AM | UKREG | Holding(s) in Company
RNS Number : 8827A
York Pharma plc
07 August 2008
TR-1: Notifications of Major Interests in Shares
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
York Pharma plc
2. Reason... More...>> |
| 08/05/2008 | 8:52AM | UKREG | Total Voting Rights
RNS Number : 6855A
York Pharma plc
05 August 2008
York Pharma PLC (the "Company")
Total Voting Rights
For the purposes of the Financial Services Authority's Disclosure and Transparency Rules, the Company's total issued share capital at
the date of this announcement is 57,082,186... More...>> |
| 08/05/2008 | 8:37AM | UKREG | Holding(s) in Company
RNS Number : 6841A
York Pharma plc
05 August 2008
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
York Pharma Plc*****..
2. Reason for the notification (please place an X... More...>> |
| 08/05/2008 | 7:34AM | UKREG | Holding(s) in Company
RNS Number : 6786A
York Pharma plc
05 August 2008
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
York Pharma Plc*****..
2. Reason for the notification (please place an X... More...>> |
| 07/31/2008 | 12:00PM | TFNF | York Pharma completes 3.9 million pounds institutional placing
York Pharma Plc. said it raised 3.9 million
pounds by way of an institutional placing of 8.90 million York Pharma shares at
a price of 44 pence per share, by FinnCap.
It added the amount will be used to co-fund the acquisition of the sales and
worldwide commercial rights to two wound care products, Flammazine... More...>> |
| 07/31/2008 | 11:18AM | UKREG | Completes GBP3.9 million institutional placing
RNS Number : 3824A
York Pharma plc
31 July 2008
York Pharma plc
('York Pharma' or 'the Company')
York Pharma completes £3.9 million institutional placing
-- £24.2 million acquisition and financing of Solvay dermatological & wound care brands due to complete in first half... More...>> |
| 07/18/2008 | 11:51AM | UKREG | Acquisition Update
RNS Number : 4495Z
York Pharma plc
18 July 2008
York Pharma plc
('York Pharma' or 'the Company')
Update on Proposed Acquisition and Financing
London, UK, 18 July 2008 - York Pharma (AIM:YRK), the specialist dermatology pharmaceutical company, announced on 4 July 2008 that it... More...>> |
| 07/07/2008 | 12:15PM | UKREG | Change of Registered Office
RNS Number : 5078Y
York Pharma plc
07 July 2008
York Pharma PLC (the "Company")
Change of Registered Office
York Pharma Plc has moved its Registered Office to York House, 327 Upper Fourth Street, Milton Keynes, MK9 1EH with immediate effect.
This address also houses the UK operating... More...>> |
| 07/04/2008 | 7:30AM | UKREG | Acquisition
RNS Number : 3660Y
York Pharma plc
04 July 2008
York Pharma plc
('York Pharma' or 'the Company')
Acquisition of leading dermatological & wound care brands, $48 million (£24.2 million) financing and £3.9 million institutional placing
London, UK, 4 July 2008 York Pharma (AIM:YRK... More...>> |
| 05/28/2008 | 5:13AM | TFNF | York Pharma H1 loss widens to 4.5 million pounds vs 3.0 million UPDATE
(Adds CEO comments)
York Pharma, the UK-based skin-care company,
has announced a first half loss widening to 4.5 million pounds, on sales of 2.2
million pounds, compared with a loss of 3.0 million last time.
Chief executive Terry Sadler told Thomson Financial News that there may be a
funding gap before... More...>> |
| 05/28/2008 | 2:30AM | TFNF | York Pharma H1 loss widens to 4.5 million pounds vs 3.0 million
York Pharma, the UK-based skin-care company,
has announced a first half loss widening to 4.5 million pounds, on sales of 2.2
million pounds, compared with a loss of 3.0 million last time.
The company said that it has 2.0 million pounds cash at the end of its half
year, compared with 2.6 million last time... More...>> |
| 05/28/2008 | 2:02AM | UKREG | Interim Results
RNS Number : 3624V
York Pharma plc
28 May 2008
York Pharma plc
(*York Pharma* or *the Company*)
Interim Results
Hitchin, UK, 28 May 2008 - York Pharma plc (AIM: YRK.L), the specialist dermatology company, today announces its interim results for the
six month period ended 31 March 2008... More...>> |
| 04/23/2008 | 5:34AM | UKREG | Blocklisting Interim Review
York Pharma plc
23 April 2008
York Pharma plc ("the Company")
Block Listing Return
1. Name of company: York Pharma plc
2. Name of scheme: N/A
3. Period of return: 24 October 2007 - 23 April 2008
4. Number & class of securities... More...>> |
| 04/14/2008 | 10:55AM | UKREG | Blocklisting Interim Review
York Pharma plc
14 April 2008
York Pharma plc ("the Company")
Block Listing Return
1. Name of company: York Pharma plc
2. Name of scheme: N/A
3. Period of return: 13 October 2007 - 12 April 2008
4. Number & class of securities... More...>> |
| 04/09/2008 | 2:57AM | TFNF | UK smallcap opening - York Pharma rises; sees H1 sales ahead of expectations
Shares in York Pharma Plc. rose 5-3/4 pence to
49-1/2 in opening trade as the company said it sees first-half sales coming in
ahead of expectations, with the company experiencing growth across all marketed
products.
Terry Sadler, CEO of the specialist dermatology company: "The integration of
Derms Development... More...>> |
| 04/09/2008 | 2:38AM | TFNF | York Pharma sees H1 sales likely ahead of expectations
York Pharma Plc., a specialist dermatology
company, said its sales for the first half are anticipated to be ahead of
expectations on growth in all marketed products, especially its Zindaclin acne
medicine.
Terry Sadler, CEO of York Pharma, said: "The integration of Derms
Development has progressed well... More...>> |
| 04/09/2008 | 2:03AM | UKREG | Trading Statement
York Pharma plc
09 April 2008
York Pharma plc
('York Pharma' or 'the Company')
Date of interim results and trading update
Hitchin, UK, 9 April 2008 York Pharma, the AIM-listed (AIM:YRK) strategic
acquirer, developer and marketer of pharmaceutical... More...>> |